New gastritis drug candidate tested in three formulations to find the best acid controller
NCT ID NCT07717775
First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time
Summary
This trial tests three different tablet versions of an experimental drug called AD-234 in healthy adults aged 19 to 50. The goal is to see which formulation best controls stomach acid levels over 24 hours after a week of daily dosing. Researchers will also compare how the body absorbs each version and check for side effects. The results will help decide which formulation to study further in people with gastritis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- an experimental drug for gastritis, tested in three different formulations called AD-234, AD-2341, and AD-2342
- What this could lead to
- If successful, this could identify the best formulation of AD-234 for controlling stomach acid, potentially leading to a new treatment option for gastritis.
- What could go wrong
- This is an early-phase trial in only 30 healthy volunteers, not people with gastritis. The drug may not work as well in actual patients or may have side effects not seen here.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Seoul National University Hospital, Seoul,
Seoul, South Korea
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New gastritis pill faces off against standard treatment in 470-Patient trial
- Simpler h. pylori treatment could reduce antibiotic use
- Gastritis drug showdown: which version works better?
- Gum bacteria linked to stomach troubles? small study investigates
- New hope for steroid users: drug may prevent stomach pain
- 120,000-Person study hopes to crack the code of chronic illness